Section Arrow
CASI.NASDAQ
- CASI Pharmaceuticals
Quotes are at least 15-min delayed:2024/12/24 12:54 EST
Last
 2.96
+0.28 (+10.45%)
Day High 
3.28 
Prev. Close
2.68 
1-M High
5.14 
Volume 
157.11K 
Bid
2.91
Ask
2.97
Day Low
2.5 
Open
2.58 
1-M Low
2.5 
Market Cap 
41.44M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.98 
20-SMA 3.36 
50-SMA 4.75 
52-W High 8.19 
52-W Low 2.05 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.23/-2.13
Enterprise Value
61.95M
Balance Sheet
Book Value Per Share
0.90
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
33.88M
Operating Revenue Per Share
2.79
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TNXPTonix Pharmaceuticals Holding Corp.0.383529-0.019571-4.86%-- 
CMNDClearmind Medicine1.695+0.475+38.93%0.16PE
CEROCERo Therapeutics Holdings0.0603+0.0098+19.41%-- 
RXRXRecursion Pharmaceuticals7.2831+0.2931+4.19%-- 
CDTConduit Pharmaceuticals0.057699+0.003199+5.87%-- 
Quotes are at least 15-min delayed:2024/12/24 12:54 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.